This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Steven M. Haffner, MD

Arch Intern Med. 1997;157(16):1791.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE RESULTS of the Diabetes Control and Complications Trial have conclusively shown that improved glycemic control decreases the incidence of retinopathy, renal disease, and neuropathy in subjects with insulin-dependent diabetes mellitus (IDDM).¹ However, a number of issues remain unresolved. Other data have suggested the existence of a glycemic threshold for diabetic proteinuria and retinopathy.^2,3 If true, this might suggest a level beyond which improved glycemic control is unnecessary, thereby potentially reducing the risk for hypoglycemia in some subjects with IDDM. However, further analyses from the Diabetes Control and Complications Trial⁴ and the EURODIAB IDDM Complications Study⁵ did not find evidence for a glycemic threshold.

The duration of diabetes is also important in assessing the risk for complications. After a long duration of diabetes, diabetic complications may develop to some degree in almost all subjects.⁶ In this issue of the ARCHIVES, Orchard et al⁷ made . . . [Full Text PDF of this Article]

Author Affiliations
University of Texas Health Science Center at San Antonio 7703 Floyd Curl Dr San Antonio, TX 78284-7873

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?